| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |